Maxime Cochin

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

De novo generation of viruses in animals: from infection models to vaccine development.

De novo generation of viruses in animals: from infection models to vaccine development.

Journal: mSphere
Published: August 11, 2025

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme.

Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme.

Journal: Vaccine
Published: June 25, 2024

In vivo rescue of arboviruses directly from subgenomic DNA fragments.

In vivo rescue of arboviruses directly from subgenomic DNA fragments.

Journal: Emerging microbes & infections
Published: May 14, 2024

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Journal: Heliyon
Published: January 09, 2024

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 05, 2023

Different viral genes modulate virulence in model mammal hosts and Culex pipiens vector competence in Mediterranean basin lineage 1 West Nile virus strains.

Different viral genes modulate virulence in model mammal hosts and Culex pipiens vector competence in Mediterranean basin lineage 1 West Nile virus strains.

Journal: Frontiers in microbiology
Published: October 19, 2023

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.

Journal: Microorganisms
Published: July 07, 2022

A One-Health Approach to Investigating an Outbreak of Alimentary Tick-Borne Encephalitis in a Non-endemic Area in France (Ain, Eastern France): A Longitudinal Serological Study in Livestock, Detection in Ticks, and the First Tick-Borne Encephalitis Virus Isolation and Molecular Characterisation.

A One-Health Approach to Investigating an Outbreak of Alimentary Tick-Borne Encephalitis in a Non-endemic Area in France (Ain, Eastern France): A Longitudinal Serological Study in Livestock, Detection in Ticks, and the First Tick-Borne Encephalitis Virus Isolation and Molecular Characterisation.

Journal: Frontiers in microbiology
Published: January 27, 2022

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.

Journal: EBioMedicine
Published: December 17, 2021

Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.

Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.

Journal: Antiviral research
Published: September 13, 2021

A simple reverse genetics method to generate recombinant coronaviruses.

A simple reverse genetics method to generate recombinant coronaviruses.

Journal: EMBO reports
Published: August 17, 2021

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.

Journal: mBio
Published: July 06, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026